ACM Research Inc has a consensus price target of $30.83 based on the ratings of 7 analysts. The high is $39 issued by Goldman Sachs on February 29, 2024. The low is $24 issued by Needham on January 10, 2024. The 3 most-recent analyst ratings were released by Needham, Benchmark, and Goldman Sachs on May 9, 2024, March 6, 2024, and February 29, 2024, respectively. With an average price target of $37 between Needham, Benchmark, and Goldman Sachs, there's an implied 78.31% upside for ACM Research Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/09/2024 | Buy Now | 63.86% | Needham | Charles Shi | → $34 | Reiterates | Buy → Buy | Get Alert |
03/06/2024 | Buy Now | 83.13% | Benchmark | Mark Miller | $35 → $38 | Maintains | Buy | Get Alert |
02/29/2024 | Buy Now | 87.95% | Goldman Sachs | Allen Chang | → $39 | Upgrade | Neutral → Buy | Get Alert |
02/29/2024 | Buy Now | 68.67% | Benchmark | Mark Miller | $32 → $35 | Maintains | Buy | Get Alert |
02/28/2024 | Buy Now | 63.86% | Needham | Charles Shi | $24 → $34 | Maintains | Buy | Get Alert |
01/11/2024 | Buy Now | 6.51% | Goldman Sachs | Allen Chang | $19.5 → $22.1 | Maintains | Neutral | Get Alert |
01/10/2024 | Buy Now | 20.48% | Roth MKM | Suji Desilva | $20 → $25 | Maintains | Buy | Get Alert |
01/10/2024 | Buy Now | 15.66% | Needham | Quinn Bolton | $18 → $24 | Maintains | Buy | Get Alert |
11/08/2023 | Buy Now | 54.22% | Benchmark | Mark Miller | → $32 | Reiterates | Buy → Buy | Get Alert |
10/12/2023 | Buy Now | -12.29% | Goldman Sachs | Allen Chang | $16.2 → $18.2 | Maintains | Neutral | Get Alert |
09/01/2023 | Buy Now | -21.93% | Goldman Sachs | Allen Chang | $14.2 → $16.2 | Maintains | Neutral | Get Alert |
08/07/2023 | Buy Now | 20.48% | Jefferies | Nick Cheng | $23.4 → $25 | Maintains | Buy | Get Alert |
08/07/2023 | Buy Now | 54.22% | Benchmark | Mark Miller | → $32 | Reiterates | Buy → Buy | Get Alert |
08/07/2023 | Buy Now | -13.25% | Needham | Quinn Bolton | → $18 | Reiterates | Buy → Buy | Get Alert |
07/21/2023 | Buy Now | -38.31% | Goldman Sachs | Allen Chang | $11.3 → $12.8 | Maintains | Neutral | Get Alert |
07/03/2023 | Buy Now | 12.77% | Jefferies | Nick Cheng | $9 → $23.4 | Upgrade | Underperform → Buy | Get Alert |
05/08/2023 | Buy Now | -27.71% | Needham | Quinn Bolton | → $15 | Reiterates | → Buy | Get Alert |
03/07/2023 | Buy Now | — | Morgan Stanley | Charlie Chan | — | Upgrade | Underweight → Overweight | Get Alert |
02/27/2023 | Buy Now | 54.22% | Benchmark | Mark Miller | → $32 | Reiterates | → Buy | Get Alert |
02/27/2023 | Buy Now | -61.45% | Jefferies | Nick Cheng | $7 → $8 | Downgrade | Hold → Underperform | Get Alert |
02/27/2023 | Buy Now | -27.71% | Needham | Quinn Bolton | → $15 | Reiterates | → Buy | Get Alert |
02/22/2023 | Buy Now | -51.81% | Morgan Stanley | Charlie Chan | → $10 | Downgrade | Equal-Weight → Underweight | Get Alert |
01/31/2023 | Buy Now | -42.17% | Needham | Quinn Bolton | $10 → $12 | Maintains | Buy | Get Alert |
01/04/2023 | Buy Now | -42.17% | Needham | Quinn Bolton | $10 → $12 | Maintains | Buy | Get Alert |
11/07/2022 | Buy Now | -66.27% | Jefferies | Nick Cheng | $8 → $7 | Upgrade | Underperform → Hold | Get Alert |
11/04/2022 | Buy Now | -51.81% | Needham | Quinn Bolton | $14 → $10 | Maintains | Buy | Get Alert |
10/18/2022 | Buy Now | -56.63% | Morgan Stanley | Charlie Chan | $28 → $9 | Downgrade | Overweight → Equal-Weight | Get Alert |
10/11/2022 | Buy Now | -61.45% | Jefferies | Nick Cheng | $33.67 → $8 | Downgrade | Buy → Underperform | Get Alert |
05/09/2022 | Buy Now | 20.48% | Needham | Quinn Bolton | $36 → $25 | Maintains | Buy | Get Alert |
01/06/2022 | Buy Now | 430.12% | Needham | Quinn Bolton | $33.33 → $36.67 | Maintains | Buy | Get Alert |
01/05/2022 | Buy Now | 526.51% | Benchmark | Mark Miller | $41.67 → $43.33 | Maintains | Buy | Get Alert |
12/17/2021 | Buy Now | 381.93% | Needham | Quinn Bolton | — | Upgrade | Hold → Buy | Get Alert |
11/08/2021 | Buy Now | 502.41% | Benchmark | Mark Miller | — | Upgrade | Hold → Buy | Get Alert |
The latest price target for ACM Research (NASDAQ:ACMR) was reported by Needham on May 9, 2024. The analyst firm set a price target for $34.00 expecting ACMR to rise to within 12 months (a possible 63.86% upside). 14 analyst firms have reported ratings in the last year.
The latest analyst rating for ACM Research (NASDAQ:ACMR) was provided by Needham, and ACM Research reiterated their buy rating.
The last upgrade for ACM Research Inc happened on February 29, 2024 when Goldman Sachs raised their price target to $39. Goldman Sachs previously had a neutral for ACM Research Inc.
The last downgrade for ACM Research Inc happened on February 27, 2023 when Jefferies changed their price target from $7 to $8 for ACM Research Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ACM Research, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ACM Research was filed on May 9, 2024 so you should expect the next rating to be made available sometime around May 9, 2025.
While ratings are subjective and will change, the latest ACM Research (ACMR) rating was a reiterated with a price target of $34.00 to $34.00. The current price ACM Research (ACMR) is trading at is $20.75, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.